Press Releases

All News
By Year:
2020
2019
2018
2017
2016

Mar 23, 2020

DiaMedica Therapeutics Announces 2019 Financial Results and Provides Business Update

Mar 17, 2020

DiaMedica Therapeutics to Report Fourth Quarter 2019 Financials and Provide a Business Update March 24, 2020

Mar 9, 2020

DiaMedica Therapeutics to Participate at 32nd Annual ROTH Conference on March 15-17, 2020

Feb 13, 2020

DiaMedica Therapeutics Announces Closing of $8.5 Million Public Offering of Common Shares

Feb 11, 2020

DiaMedica Announces Pricing of Public Offering of Common Shares

Dec 17, 2019

DiaMedica Therapeutics Announces First Patient Dosed in REDUX Phase II Clinical Trial of DM199 for the Treatment of Chronic Kidney Disease

Nov 13, 2019

DiaMedica Therapeutics Announces Third Quarter 2019 Financial Results and Provides Business Update

Nov 6, 2019

DiaMedica Therapeutics to Report Third Quarter 2019 Financials and Provide a Business Update November 14, 2019

Nov 5, 2019

DiaMedica Therapeutics to Participate in 10th Annual Craig-Hallum Alpha Select Conference

Oct 14, 2019

DiaMedica Therapeutics Announces Clearance to Initiate Phase II Clinical Trial of DM199 for Chronic Kidney Disease

<< Previous
1
2
3
4
5
6
7
8
9
Next >>